Genzyme, a global biotechnology company, launches a plan to develop therapies for neglected diseases, (e.g. malaria, TB), giving away the intellectual property.
This case targets the decision of which disorders, which ventures, and which markets should management decide to fund. However the larger issue is how this program urbanized under the umbrella part Genzyme's corporate social responsibility fits into its international competitive strategy.
PUBLICATION DATE: August 20, 2009 PRODUCT #: 910407-PDF-ENG
This is just an excerpt. This case is about GLOBAL BUSINESS
Related Case Solutions & Analyses:
Internationalizing the Cola Wars (A): The Battle for China and Asian Markets
Shifting Sands of Competitive Advantage
Microsoft–1995
Digital Communications Inc.: Encoder Device Division
Skil Corp.
Colt Industries
An Tai Bao Coal Mining Project
Roles and Relationships of Business and Government
Google Inc. in 2014
PepsiCo’s Turning Point: Establishing a Role in a Sustainable Society
